STAT

LISTEN: Watson’s latest stumble, a glimpse into the crystal ball, and revisiting Sarepta

What will become of biotech in 2019? What's the legacy of Sarepta Therapeutics? And how do you say "overhyped" in Mandarin?

What will become of biotech in 2019? What’s the legacy of Sarepta Therapeutics? And how do you say “overhyped” in Mandarin?

You're reading a preview, sign up to read more.

More from STAT

STAT3 min readSociety
Opinion: Policymakers Are Taking The Wrong Approach To Health Care Reform
Lawmakers need to listen to people with chronic illnesses, who know all too well the damage that can come from unexpected changes to treatment plans caused by poorly thought-out drug…
STAT4 min readSociety
Opinion: U.S. Continues To Lead The Fight Against Antibiotic Resistance
Everyone must help wage war against #antibiotic resistance: Use antibiotics only as prescribed. Wash your hands, cover wounds, and get recommended vaccines. Prepare food safely. Use safe sex practices.
STAT2 min readSociety
Aurinia’s Drug To Treat Autoimmune Kidney Disease Hits Its Goals In Late-stage Trial
Aurinia Pharmaceuticals' experimental drug for lupus nephritis, an autoimmune kidney disease, achieved all efficacy goals in a late-stage clinical trial.